Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer
An early-stage experimental study conducted by Zhejiang Cancer Hospital to evaluate technologies for gastric cancer screening; recruitment i…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the combination of S-1 and cisplatin in advanced gastric cancer; the study is listed as completed.
-
CLINICAL_TRIALS other · 2024-08-30Clinical Trial Update: Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers [Phase 2]
Phase 2 trial evaluating immune checkpoint inhibitors for organ preservation in non-metastatic dMMR/MSI-H gastric or colon cancers; currentl…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Immunonutrition and Psychosocial Factors in the Recovery of Patients After Gastrectomy: a Multidimensional Analysis
A clinical trial assessing the effects of immunonutrition and psychosocial factors on recovery after gastrectomy in gastric cancer patients;…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis
A clinical trial sponsored by the Chinese University of Hong Kong is studying prediction of gastric cancer risk in patients with intestinal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis [Phase 2]
A Phase 2 trial evaluating the combination of sintilimab and ramucirumab with chemotherapy as first-line treatment for gastric cancer with l…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma [Phase 3]
A Phase 3 trial evaluating nimotuzumab in combination with paclitaxel for recurrent/metastatic gastric cancer or esophagogastric junction ad…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant Therapy
A completed clinical trial assessing whether hematological dynamic scores can predict survival and treatment response in patients with advan…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating disitamab vedotin in combination with trastuzumab in patients with HER2-positive gastric cancer …
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer [NA]
A not-yet-recruiting clinical trial evaluating a liposomal irinotecan combination regimen as second-line therapy for advanced gastric cancer…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization [NA]
A clinical trial update describing research on a bioorthogonal nuclide probe for visualizing gastric cancer mucin to enable early diagnosis;…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer [NA]
A completed clinical trial evaluating the effects of red ginseng on postoperative gastrointestinal symptoms and gut microbiota in cancer pat…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam [NA]
A completed Yonsei University trial aimed to identify the ED90 dose of flumazenil to selectively reverse respiratory distress associated wit…
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression [Phase 2]
Phase 2 trial evaluating disitamab vedotin combined with tislelizumab and capecitabine as perioperative treatment for locally advanced, HER2…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma [Phase 1]
A Phase 1 trial of NT-I7 in combination with nivolumab for advanced gastric, gastroesophageal junction, or esophageal adenocarcinoma has bee…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) [Phase 2]
Phase 2 study MK-2140-002 evaluating Zilovertamab vedotin (VLS-101) in solid tumors including triple-negative breast cancer and non-small-ce…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy [NA]
This clinical trial update describes a preliminary efficacy analysis of the λ+α Double-Tract Reconstruction after laparoscopic proximal gast…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer [Phase 2]
A single-arm Phase II exploratory trial evaluating sintilimab with chemoradiotherapy in elderly patients with locally advanced gastric cance…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: The Therapeutic Efficacy of 18F-FDG Combined With 18F-FAPI PET/MR in Neoadjuvant Therapy for Gastric Cancer
An ongoing clinical trial is evaluating the use of combined 18F-FDG and 18F-FAPI PET/MR imaging in the neoadjuvant setting for gastric cance…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating infigratinib in patients with locally advanced or metastatic gastric cancer or gastroesophageal junction adenocar…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor [Phase 2]
Phase 2 clinical trial update on pemigatinib plus an immune checkpoint inhibitor for FGFR1/2/3-altered advanced solid tumors; the study is n…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes
A clinical trial is investigating HER2 status (HER2-positive vs HER2-low) in esophagogastric adenocarcinoma and its associations with clinic…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients
A completed clinical trial investigates interpretable machine learning models to predict prognosis in gastric cancer patients.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer [Phase 2]
A Phase 2 study comparing Modified FOLFOX with or without nivolumab and ipilimumab versus FLOT with nivolumab in previously untreated advanc…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 study of CAR-T cells targeting the carcinoembryonic antigen (CEA) for CEA-positive…